Aster DM Healthcare announced that the Board of Directors of the Company at its meeting held on 31 January 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Aster DM Healthcare declined 68.31% to Rs 56.79 crore in the quarter ended December 2024 as against Rs 179.21 crore during the previous quarter ended December 2023. Sales rose 9.97% to Rs 1049.81 crore in the quarter ended December 2024 as against Rs 954.67 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1049.81954.67 10 OPM %17.6815.63 - PBDT187.81133.12 41 PBT125.6076.61 64 NP56.79179.21 -68 Powered by Capital Market - Live News

Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live News

Aster DM Healthcare and Quality Care India backed by Blackstone and TPG, one of the largest privately held hospital chains in India with a focus on emerging cities, have today signed definitive agreements for a merger. The merger has been approved by the Board of Directors of the respective companies and is subject to regulatory, corporate and shareholders` approvals. The merged listed entity will be named Aster DM Quality Care.Aster DM Quality Care will have a combined portfolio of four leading brands: Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. The combined entity will have a of network of 38 hospitals and 10,150+ beds spread across 27 cities making it one of the top 3 hospital chains in India. Aster is valued at a multiple of 36.6x on FY24 adjusted post IND AS EV/ EBITDA. In comparison, QCIL is valued at a multiple of 25.2x based on FY24 adjusted post IND AS EV/ EBITDA. Based on the swap ratio recommended in the valuation report, the resultant shareholding of the Merged Entity will be 24.0% and 30.7% held by Aster Promoters and Blackstone respectively, with the balance 45.3% being held by public and other shareholders.Ahead of this merger, Aster shall purchase 5.0% stake in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake (Initial Share Acquisition). Post the Initial Share Acquisition, QCIL will be merged into Aster by way of a scheme of amalgamation. The transaction is subject to shareholder & regulatory approvals, and other customary conditions to closing. Aster expects the merger transaction to close by Q3 FY26. The ratio for the Initial Share Acquisition is the same as proposed for the merger. Powered by Capital Market - Live News

Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 29 November 2024Powered by Capital Market - Live News